,i #aagth ,,congress #b;d ,session ,h4 ,r4 #gjce ,,in ,,the ,,house ,,of ,,representatives ,march #i1 #bjbb,ms4 ,manning 7for herself and ,mr4 ,hudson7 introduced the following bill2 which was referred to the ,committee on ,energy and ,commerce ,a ,,bill ,to amend the ,federal ,food1 ,drug1 and ,cosmetic ,act to require prompt reports of marketing status by holders of approved applications for biological products1 and for other purposes4 #a4 ,short title ,this ,act may be cited as the ,biologics ,market ,transparency ,act of #bjbb 4 #b4 ,prompt reports of marketing status by holders of approved applications for biological products 7a7 ,in general ,section #ejf;,i of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cef;i7 is amended-- 7#a7 in subsection 7a7-- 7,a7 by striking ,the holder of an application approved under subsection 7c7 or 7j7 of section #eje and inserting ,the holder of an application approved under subsection 7c7 or 7j7 of section #eje of this ,act or subsection 7a7 or 7k7 of section #cea of the ,public ,health ,service ,act2 and 7,b7 in paragraph 7#c71 by striking or abbreviated application number and inserting 1 abbreviated application number1 or biologics license application number2 and 7#b7 in subsection 7b7-- 7,a7 by striking ,the holder of an application approved under subsection 7c7 or 7j7 and inserting ,the holder of an application approved under subsection 7c7 or 7j7 of section #eje of this ,act or subsection 7a7 or 7k7 of section #cea of the ,public ,health ,service ,act2 and 7,b7 in paragraph 7#b71 by striking or abbreviated application number and inserting 1 abbreviated application number1 or biologics license application number4 7b7 ,additional one-,time report ,subsection 7c7 of section #ejf;,i of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cef;i7 is amended to read as follows3 7c7 ,additional one-,time report ,within #ahj days of the date of enactment of the ,biologics ,market ,transparency ,act of #bjbb1 all holders of applications approved under subsection 7a7 or 7k7 of section #cea of the ,public ,health ,service ,act shall review the information in the list published under section #cea7k77#i77;,a7 and shall submit a written notice to the ,secretary-- 7#a7 stating that all of the application holder's biological products in the list published under section #cea7k77#i77;a7 that are not listed as discontinued are available for sale2 or 7#b7 including the information required pursuant to subsection 7a7 or 7b71 as applicable1 for each of the application holder's biological products that are in the list published under section #cea7k77#i77;a7 and not listed as discontinued1 but have been withdrawn from sale or never have been available for sale4 4 7c7 ,purple ,book ,subsections 7d7 and 7e7 of section #ejf;,i of the ,federal ,food1 ,drug1 and ,cosmetic ,act 7#ba ,u4,s4,c4 #cef;i7 are each amended-- 7#a7 by striking the list published under subsection #eje7;j77#g77;,a7 and inserting the list published under section #eje7;j77#g77;,a7 of this ,act or section #cea7k77#i77;,a7 of the ,public ,health ,service ,act1 as applicable12 and 7#b7 by striking in accordance with subsection #eje7;j77#g77;,c7 and inserting in accordance with section #eje7;j77#g77;,c7 of this ,act or section #cea7k77#i77;,b7 of the ,public ,health ,service ,act 7as applicable74